Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Pharmaceutical

Daiichi Sankyo

Ken Keller

Federico Nasroulah

Caleb Lee

Mohini Rajasagi

Thomas Dusserre

Leena Patel Shah

Brandon Fox

Amit Mahadevia

John Toso

Ahmed Kotb

Allison Smith

Gissoo Decotiis

Craig Gibson

Radha Ramkumar

Everest Nwakamma

John Harkins

Stephen R. Esker

Tomek Szczudlo

Rich Jones

Kenji Shigeta

Ray Bedeaux

Barry Noble

Ken Takeshita

Rodney B. Smith

Ouzna Morsli

Amy Todd Klug

Kelly Serritella

James Kerwin

Meg Lindsay

Barbara Tantillo Rn Bsn

Daniel Switzer

Hiroyuki Fujita

Dick Van Duyne

The Leadership Team at Daiichi Sankyo is responsible for guiding the strategic direction of the company, overseeing research and development initiatives, and ensuring the successful commercialization of pharmaceutical products. This team, consisting of top executives from various functions such as oncology, regulatory operations, and global marketing, collaborates to drive innovation, enhance operational efficiency, and optimize product access in global markets. Their leadership fosters a culture of excellence and empowers teams to achieve Daiichi Sankyo's mission of improving patient outcomes through advanced therapies.

Leadership Team

The Clinical Operations and Management team at Daiichi Sankyo is responsible for the strategic planning, execution, and oversight of clinical trials throughout the drug development process. This team ensures operational excellence, coordinates resources, and manages collaborations with external partners to deliver high-quality clinical data efficiently. Their focus on oncology programs highlights their commitment to advancing innovative treatments while adhering to regulatory standards and best practices in clinical research.

Clinical Operations and Management

The Marketing and Communications team at Daiichi Sankyo focuses on developing and implementing strategic marketing initiatives to promote the company's oncology products. They collaborate on global marketing campaigns, ensure effective product communication, and enhance brand visibility through omnichannel strategies, all while supporting the launch of new pharmaceutical offerings. This team plays a pivotal role in engaging healthcare professionals and patients, driving awareness and understanding of Daiichi Sankyo’s innovative treatments in oncology.

Marketing and Communications

The Research and Development Support team at Daiichi Sankyo plays a crucial role in enhancing the efficiency and effectiveness of the pharmaceutical development process. This team focuses on data governance, clinical operations, outsourcing, and ensuring quality throughout research projects. By utilizing advanced data architecture and statistical programming, they support cross-functional collaboration and communication, ensuring innovative therapies are developed and brought to market successfully.

Research and Development Support

��

Daiichi Sankyo

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Management

Marketing and Communications

Research and Development Support

Offices

��������

Daiichi Sankyo

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Management

Marketing and Communications

Research and Development Support

Offices

Related companies

��